Thomas Geelhaar, Head of Chemicals R&D at Merck in Darmstadt, Germany, describes how the company scouts for technologies and interacts with universities.
ITI Life Sciences, Scotland’s publicly funded innovation group, is to invest a further £2 million in its programme to develop new drug discovery tools.
Radiologists are in short supply in parts of Europe. Telemedicine Clinic solves the problem by remote control, with a network of doctors who diagnose patients on the basis of medical images that arrive by email.
Call the Presidential candidates to account for science and make sure they recognise scientific issues are global, says world-leading biologist and Nobel laureate David Baltimore.
Thin drug pipelines prompted the biopharmaceuticals licensing splurge of 2006/7. Now pharma and large biotechs are looking to tap into university research too.
Tough news for America. China’s technological development is set to make it the main driver of world’s economy – and an integrated Europe could overtake it too.
The exchange of knowledge requires professional people who understand how to do it – including how to manage IP, says Gilles Capart from ProTon Europe.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.